Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has a negative trailing P/E of -0.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -995.19%.
Criteria proven by this page:
Overall SharesGrow Score: 33/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2017 | -489,531.0 | 0.00 | -367,721.53 | 0.00 | - |
| 2018 | -166,993.1 | -862.43 | 3,808,307.13 | 0.00 | - |
| 2020 | -129,771.3 | 0.00 | -61,859.51 | 0.00 | - |
| 2021 | -90,754.1 | -2,378.38 | -64,221.38 | 0.00 | - |
| 2022 | -812.2 | -3.73 | 528.48 | 0.00 | - |
| 2023 | -219.6 | -5.99 | 356.90 | 0.00 | - |
| 2024 | -24.3 | 0.00 | 312.73 | 0.00 | - |
| 2025 | -0.3 | 0.00 | 1.31 | 0.00 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2017 | $-0.02 | $0.00 | $-213.59K | - |
| 2018 | $-0.05 | $0.00 | $-626.14K | - |
| 2020 | $-0.06 | $0.00 | $-845.36K | - |
| 2021 | $-0.09 | $0.00 | $-1.2M | - |
| 2022 | $-0.30 | $0.00 | $-3.1M | - |
| 2023 | $-0.41 | $0.00 | $-6.59M | - |
| 2024 | $-3,167.28 | $0.00 | $-9.14B | - |
| 2025 | $-7.16 | $0.00 | $-11.72M | - |